Lumiracoxib 400 mg, én gang daglig var effektivt smertelindrende i korterevarende kliniske forsøg med gentagne doser ved post- operative ortopædiske smerter og smerter fra primær dysmenorré.
In short-term, multiple-dose clinical studies of post-orthopaedic surgical pain and pain from primary dysmenorrhea, lumiracoxib 400 mg once daily was effective in relieving pain.